Clinical Trials Logo

Clinical Trial Summary

The goal of this randomized controlled trial is to investigate operative treatment versus conservative treatment in participants suffering from mild to moderate hallux valgus deformity. The main question it aims to answer are; Is surgery superior to conservative treatment? The participants will be randomized in to two groups, operative and conservative group. Investigators will compare the groups measuring the clinical results using the patient-reported outcome measure (PROM) Manchester-Oxford Foot Questionnaire (MOxFQ), Visual analog scale (VAS), likert scale 0-5. Participants will be observed for a period og two years.


Clinical Trial Description

Randomized controlled trial (RCT) investigating the patient reported outcome after operative or conservative treatment in mild to moderate hallux valgus deformity. In this RCT study participants will be divided into operative group, non-operative group where the treatment will be orthopedic aids/wide shoes. The participants will be evaluated 6 months, 1 year and 2 years after starting the treatment. The clinical results will be evaluated using patient reported outcome measures (PROMs). Primary aim: Investigating the clinical result by PROM (Manchester Oxford Foot Questionnaire) Secondary aim: Investigating the radiological results according to newer and traditional parameters. Operative group -correction achieved, residual rate. Conservative group -progression of deformity. Statistical power calculations have been made within the research group. Calculations are based on the main outcome MOxFQ, with the power of 80 and confidence interval 95%. We concluded that a sample size of 49 participants will be needed to perform a regression analysis. To account for loss to follow-up (estimated 20%) we will recruit 120 participants (60 per group). ;


Study Design


Related Conditions & MeSH terms


NCT number NCT06114043
Study type Interventional
Source Ostfold Hospital Trust
Contact Marius Molund
Phone 90093988
Email marius.molund@so-hf.no
Status Not yet recruiting
Phase N/A
Start date March 2024
Completion date March 2030

See also
  Status Clinical Trial Phase
Completed NCT03307837 - A Phase 1 Study of Intraoperative Administration of CA-008 for the Correction of Hallux Valgus Deformity Phase 1